The Mechanism of Photobiomodulation
Photobiomodulation therapy (PBMT) uses specific wavelengths of red and near-infrared light — most commonly in the 630–660 nm and 810–850 nm ranges — that are absorbed by mitochondrial cytochrome c oxidase. This absorption transiently increases ATP production, modulates reactive oxygen species signaling, and influences the expression of inflammatory mediators in the exposed tissue.
The dose response is not linear: too little energy produces no measurable effect, and too much can attenuate the benefit. That's why Sanctuary Tulum operates PBMT as a supervised protocol inside the Pouyan Method™, with wavelength, distance, and session length matched to the guest's goals rather than as a one-size-fits-all wellness ritual.
What the Evidence Supports
- • Reduced pain and improved recovery in musculoskeletal and post-exercise settings
- • Improved wound healing and reduced local inflammation
- • Emerging evidence for transcranial PBM in traumatic brain injury and mood symptoms
- • Improvements in skin quality and collagen expression with sustained use
- • Adjunct support for post-ceremony recovery and sleep quality in guest-reported outcomes
How It Sits Inside the Protocol
PBMT is deliberately paired with other recovery modalities — hyperbaric oxygen therapy, NAD+ IV therapy, and stem cell therapy — so guests receive coordinated cellular-support work rather than isolated sessions. Alongside infrared sauna and cold plunge, it forms part of the daily recovery block.
What a Supervised PBM Session Involves
A typical session at Sanctuary Tulum begins with a review of dose targets — wavelength, irradiance, distance, and treatment time. This matters because the biological response to photobiomodulation is biphasic: an under-dosed session produces no measurable effect, while an over-dosed one can attenuate the very benefit being sought. Guests wear appropriate eyewear, and treatment areas are prepared to be free of thick lotions, sunscreens, and reflective clothing that would scatter the light.
Most sessions run 10–20 minutes. The panel or cabin position is set so that the target tissue receives the intended energy density (J/cm²) — a variable that popular consumer devices rarely disclose, and that we track deliberately. Guests scheduled for transcranial sessions receive a lower-irradiance targeted setup rather than a full-body cabin, since the goal for those sessions is very different from a musculoskeletal or skin-focused protocol.
After the session, guests are asked to note any changes in local warmth, sleep quality, and perceived recovery. These are logged alongside other daily markers so the clinical team can spot whether the modality is producing meaningful effects for that particular guest, or whether the schedule should be adjusted or the modality replaced with something better matched.
The Limits of What We Claim
Photobiomodulation is not a treatment for addiction, mental illness, cancer, or neurodegenerative disease. It is a well-tolerated modality with real evidence for a specific list of endpoints — musculoskeletal pain, wound healing, local inflammation, and a growing body of work in transcranial applications — and we present it in those terms. Language like "cellular regeneration" and "neurogenesis" belongs in a discussion of mechanism, not in a promise of outcome.
That framing lets us use PBMT for what it is actually good at inside a supervised protocol, without asking it to do the work of IV nutrition, hyperbaric therapy, or the integration and lifestyle changes that anchor lasting recovery.
Related Resources
- → Infrared Sauna Therapy
- → Stem Cell Therapy
- → Hyperbaric Oxygen Therapy
- → The Pouyan Method™
- → All Treatments
References
- 1. Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361.
- 2. Naeser MA, Zafonte R, Krengel MH, et al. Significant improvements in cognitive performance post-transcranial, red/near-infrared LED treatments in chronic mild TBI: open-protocol study. J Neurotrauma. 2014;31(11):1008-1017.
- 3. Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Neurophotonics. 2016;3(3):031404.
